Tech Company Financing Transactions

Avalanche Biotech Funding Round

Avalanche Biotech closed a $55 million Series B funding round on 4/23/2014. Investors included Venrock, Adage Capital Management and Deerfield Capital.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series B
Proceeds Purpose
Proceeds from the Series B financing round will be used to advance the company's clinical programs in retinal disorders, including Avalanche's lead product, AVA-101, for wet AMD.

Company Information

Company Status
Private & Independent
Mailing Address
1035 O'Brien Dr. A
Menlo Park, CA 94025
Email Address
Avalanche develops technologies and products for sustained delivery of therapeutic proteins to the eye to treat ophthalmologic disorders.
Avalanche Biotech LinkedIn Company Profile
Social Media
Avalanche Biotech Company Twitter Account
Company News
Avalanche Biotech News
Avalanche Biotech on Facebook
Avalanche Biotech on YouTube

Management Team

Email & Social
Chief Executive Officer
Leone Patterson
  Leone Patterson LinkedIn Profile  Leone Patterson Twitter Account  Leone Patterson News  Leone Patterson on Facebook
Chief Medical Officer
Aaron Osborne
  Aaron Osborne LinkedIn Profile  Aaron Osborne Twitter Account  Aaron Osborne News  Aaron Osborne on Facebook
Chief Technical Officer
Thomas Leung
  Thomas Leung LinkedIn Profile  Thomas Leung Twitter Account  Thomas Leung News  Thomas Leung on Facebook
Mehdi Gasmi
  Mehdi Gasmi LinkedIn Profile  Mehdi Gasmi Twitter Account  Mehdi Gasmi News  Mehdi Gasmi on Facebook
VP - General Counsel
Jennifer Cheng
  Jennifer Cheng LinkedIn Profile  Jennifer Cheng Twitter Account  Jennifer Cheng News  Jennifer Cheng on Facebook
VP - Regulatory Affairs
Carla Fiankan
  Carla Fiankan LinkedIn Profile  Carla Fiankan Twitter Account  Carla Fiankan News  Carla Fiankan on Facebook



Browse more venture capital transactions:

Prev: 4/23/2014: HackSurfer venture capital transaction
Next: 4/23/2014: Kala Pharmaceuticals venture capital transaction


Share this article


Where The Data Comes From

We do our best to document every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data is sourced from, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary